ASO visual abstract: RAS mutation status should not be used to predict outcome from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases
Bhullar, Dilraj O'Dwyer, Sarah T Wilson, Malcolm S Saunders, Mark P Kochhar, Rohit Barriuso, Jorge Aziz, Omer
Bhullar, Dilraj
O'Dwyer, Sarah T
Wilson, Malcolm S
Saunders, Mark P
Kochhar, Rohit
Barriuso, Jorge
Aziz, Omer
Citations
Altmetric:
Abstract
None
Description
Date
2022
Publisher
Collections
Keywords
Type
Article
Citation
Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, et al. ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases. Ann Surg Oncol. 2022 Nov 20. PubMed PMID: 36404378. Epub 2022/11/21. eng.